Jacobson Pharma's IFRS net profit for 6 months of 2021 fiscal year was HK$112.453 million, down 14.7% from HK$131.879 million in the previous year. Revenue decreased by 8.2% to HK$695.425 million against HK$757.207 million in the previous year.
Jacobson Pharma's IFRS net profit for 6 months of 2021 fiscal year was HK$112.453 million, down 14.7% from HK$131.879 million in the previous year. Revenue decreased by 8.2% to HK$695.425 million against HK$757.207 million in the previous year. 
www1.hkexnews.hk
English (US) 